Cargando…

The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis

OBJECTIVE: To systematically evaluate the effectiveness of exposure and response prevention (ERP) combined with medication on obsessive-compulsive disorder (OCD). METHODS: PubMed, Web of Science, EBSCO, Cochrane, Embase, and Science Direct databases were searched to include randomized controlled tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Lingyun, Hu, Maorong, Luo, Lan, Wu, Yunhong, Lu, Zihang, Zou, Jingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520065/
https://www.ncbi.nlm.nih.gov/pubmed/36186855
http://dx.doi.org/10.3389/fpsyt.2022.973838
_version_ 1784799540411367424
author Mao, Lingyun
Hu, Maorong
Luo, Lan
Wu, Yunhong
Lu, Zihang
Zou, Jingzhi
author_facet Mao, Lingyun
Hu, Maorong
Luo, Lan
Wu, Yunhong
Lu, Zihang
Zou, Jingzhi
author_sort Mao, Lingyun
collection PubMed
description OBJECTIVE: To systematically evaluate the effectiveness of exposure and response prevention (ERP) combined with medication on obsessive-compulsive disorder (OCD). METHODS: PubMed, Web of Science, EBSCO, Cochrane, Embase, and Science Direct databases were searched to include randomized controlled trials of ERP combined with medication for OCD that met the criteria. The Yale Brown Obsessive Compulsive Scale was used as the primary outcome indicator, and Depression scales were used as secondary outcome indicators. An evaluation of bias risk was conducted to identify possible sources of bias based on methodological and clinical factors. Review Manager 5.3 and Stata 16.0 software was used to perform meta-analysis of the extracted data. RESULTS: A total of 21 studies with 1113 patients were included. Meta-analysis showed that ERP combined with medication therapy was significantly better than medication therapy alone including selective serotonin reuptake inhibitors, clomipramine and risperidone (MD = –6.60, 95% CI: –8.35 to –4.84, P < 0.00001), but D-cycloserine (DCS) drugs do not enhance the effect of ERP intervention in patients with OCD (MD = 0.15, 95% CI: –0.87 to 1.17, P = 0.77). There is more significant maintenance by combined treatment method of medication plus ERP than medication treatment alone during the follow-up period (MD = –7.14, 95% CI: –9.17 to –5.10, P < 0.00001). DCS drugs did not enhance the effect of ERP intervention on depression in patients with OCD (SMD = –0.08, 95% CI: –0.31 to 0.15, P = 0.50). ERP combined with drug improved patients’ depression levels significantly better than providing drug alone (SMD = –0.40, 95% CI: –0.68 to –0.11, P = 0.006). CONCLUSION: Patients with OCD have significant improvement in symptoms of obsessive-compulsive disorder and depression when ERP is combined with medication, however, not enough to prove that DCS can enhance ERP effectiveness.
format Online
Article
Text
id pubmed-9520065
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95200652022-09-30 The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis Mao, Lingyun Hu, Maorong Luo, Lan Wu, Yunhong Lu, Zihang Zou, Jingzhi Front Psychiatry Psychiatry OBJECTIVE: To systematically evaluate the effectiveness of exposure and response prevention (ERP) combined with medication on obsessive-compulsive disorder (OCD). METHODS: PubMed, Web of Science, EBSCO, Cochrane, Embase, and Science Direct databases were searched to include randomized controlled trials of ERP combined with medication for OCD that met the criteria. The Yale Brown Obsessive Compulsive Scale was used as the primary outcome indicator, and Depression scales were used as secondary outcome indicators. An evaluation of bias risk was conducted to identify possible sources of bias based on methodological and clinical factors. Review Manager 5.3 and Stata 16.0 software was used to perform meta-analysis of the extracted data. RESULTS: A total of 21 studies with 1113 patients were included. Meta-analysis showed that ERP combined with medication therapy was significantly better than medication therapy alone including selective serotonin reuptake inhibitors, clomipramine and risperidone (MD = –6.60, 95% CI: –8.35 to –4.84, P < 0.00001), but D-cycloserine (DCS) drugs do not enhance the effect of ERP intervention in patients with OCD (MD = 0.15, 95% CI: –0.87 to 1.17, P = 0.77). There is more significant maintenance by combined treatment method of medication plus ERP than medication treatment alone during the follow-up period (MD = –7.14, 95% CI: –9.17 to –5.10, P < 0.00001). DCS drugs did not enhance the effect of ERP intervention on depression in patients with OCD (SMD = –0.08, 95% CI: –0.31 to 0.15, P = 0.50). ERP combined with drug improved patients’ depression levels significantly better than providing drug alone (SMD = –0.40, 95% CI: –0.68 to –0.11, P = 0.006). CONCLUSION: Patients with OCD have significant improvement in symptoms of obsessive-compulsive disorder and depression when ERP is combined with medication, however, not enough to prove that DCS can enhance ERP effectiveness. Frontiers Media S.A. 2022-09-15 /pmc/articles/PMC9520065/ /pubmed/36186855 http://dx.doi.org/10.3389/fpsyt.2022.973838 Text en Copyright © 2022 Mao, Hu, Luo, Wu, Lu and Zou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Mao, Lingyun
Hu, Maorong
Luo, Lan
Wu, Yunhong
Lu, Zihang
Zou, Jingzhi
The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis
title The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis
title_full The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis
title_fullStr The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis
title_full_unstemmed The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis
title_short The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis
title_sort effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: a systematic review and meta-analysis
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520065/
https://www.ncbi.nlm.nih.gov/pubmed/36186855
http://dx.doi.org/10.3389/fpsyt.2022.973838
work_keys_str_mv AT maolingyun theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis
AT humaorong theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis
AT luolan theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis
AT wuyunhong theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis
AT luzihang theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis
AT zoujingzhi theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis
AT maolingyun effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis
AT humaorong effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis
AT luolan effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis
AT wuyunhong effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis
AT luzihang effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis
AT zoujingzhi effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis